EyePoint Assist: Leave Reimbursement Risk Behind

Sponsored by EyePoint Pharmaceuticals
Dexycu (dexamethasone intraocular suspension) 9%

Read Digital Edition

Read PDF Edition

Current Issue

April 2024

Table of Contents

Read Digital Edition

Read PDF Edition

Archive

Subscriptions